Guns, drugs, emojis: Trial reveals a rare behind-the-scenes look at a Syracuse gang
A trial this month gave a rare, behind-the-scenes look at Syracuse street gang. The Uptown gang has been connected to drug ...
AI-developed drug will be in trials by year-end, says Google’s Hassabis
Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...
E-sellers of compounded weight-loss drugs fail to reveal risks, research shows
Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...
Trio standing trial in NYC gay nightclub drug deaths ‘callously’ abandoned OD victims, went on high-end shopping sprees with stolen money: DA
Jayqwan Hamilton, 37, Robert DeMaio, 36, and Jacob Barroso, 32 -- shuffled into a Manhattan courtroom for the first day of a ...
‘Deadly Conspiracy’ Described at Trial of 3 Charged in Gay Bar Murders
Three men have been accused of murder as part of a plot to drug and rob revelers in Midtown in 2022. Two of their targets ...
ReadWrite14h
Trials of drugs developed with AI could begin this year, Google DeepMind CEO says
The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.
Pregnant women often left out of drug trials, study finds
A new study by researchers from the Brown University School of Public Health found that pregnant women are regularly excluded ...
The Next Web1d
Europe accelerates AI drug discovery as DeepMind spinoff targets trials this year
Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...
The Dangers Hidden In CMS’ Drug Pricing Regulation
The IRA’s price controls discourage post-marketing research. The potential benefits from expanding access to the drug to ...
Google Parent-Owned Startup To Launch AI-Designed Drug Trials By Year-End, Partnering With Eli Lilly And Novartis To Tackle Major Diseases
An Alphabet-backed startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end.
The Lancet2h
Delivery of drugs through the blood–brain barrier: need for trials
The blood–brain barrier is the biggest challenge to the development of drugs that target the CNS. Most capillary beds leak plasma contents between and across endothelial cells by way of window-like ...